Opexa Announces Encouraging Clinical Data on Novel T-Cell ...
Business Wire (press release) - San Francisco,CA,USA
The Company’s lead product, Tovaxin™, a T-cell therapy for multiple sclerosis is in Phase IIb trials. The Company holds the exclusive worldwide license for ...

Antisense and Isis Extend Pact
Genetic Engineering News (press release) - New Rochelle,NY,USA
Through this agreement and its extension ANP intends to add new products its pipeline, which currently includes ATL1102 for multiple sclerosis and ATL1103 ...

Antisense Therapeutics Extends its Drug Discovery and Development ...
PipelineReview.com (press release) - Barcelona,Spain
The intent of this agreement and its extension is to add new products to ANP’s current drug development pipeline which includes ATL1102 for multiple ...

Pawlenty threatens veto of unrestricted stem cell legislation KARE 11 Minneapolis-St. Paul Tue, 06 Feb 2007 8:49 AM PST Stem cell research legislation that doesn't explicitly restrict the use of embryonic cells would face a gubernatorial veto, Gov. Tim Pawlenty said Monday,

MultiCell Technologies Announces Progress for MCT-125's Anticipated Phase IIb Clinical Trial RedNova Tue, 06 Feb 2007 3:19 AM PST MultiCell Technologies, Inc. (OTCBB:MCET), dev

Madman or hero? The medical maverick who let 50 hookworms burrow into his arm
Daily Mail Tue, 06 Feb 2007 3:21 AM PST
In search of a cure for asthma, Professor David Pritchard wanted to test the effects of parasites on humans. So he let 50 hookworms burrow into his arm